The added value of risk assessment and subsequent targeted treatment for epileptic seizures after stroke: An early-HTA analysis

DISCUSSION: We showed that a risk assessment for PSE development is potentially valuable. This work demonstrates that it is worthwhile to undertake clinical studies to evaluate biomarkers for the prediction of patients at high risk for PSE and to assess the value of targeted prophylactic treatment.PMID:38159505 | DOI:10.1016/j.yebeh.2023.109594

Source: Epilepsy and Behaviour - December 30, 2023 Category: Neurology Authors: Elles P Elschot Manuela A Joore Rob P W Rouhl Rob J Lamberts Walter H Backes Jacobus F A Jansen Source Type: research